This session will explore the genetic and biochemical pathways that contribute to HIV drug resistance. Emphasis will be placed on recent discoveries that enhance our understanding of resistance mechanisms at the molecular level.

This track will focus on the latest advancements in molecular diagnostics for HIV detection and drug resistance testing. Participants will discuss the implications of these innovations for early intervention and patient management.

This session will address the design and implementation of clinical trials aimed at evaluating new therapeutic interventions for HIV. Key challenges and opportunities in recruiting diverse populations and measuring outcomes will be highlighted.

This track will examine current and emerging therapeutic strategies for managing HIV infection and drug resistance. Discussions will include combination therapies, novel drug classes, and personalized medicine approaches.

This session will focus on the importance of patient-centered care in the management of HIV and drug resistance. Strategies to enhance treatment adherence and improve health outcomes will be critically analyzed.

This track will showcase cutting-edge laboratory techniques and technologies that are advancing HIV research. Topics will include high-throughput screening, next-generation sequencing, and bioinformatics applications.

This session will highlight the importance of translational research in bridging the gap between laboratory findings and clinical applications in HIV drug resistance. Case studies illustrating successful translational efforts will be presented.

This track will provide insights into the epidemiological trends of HIV drug resistance globally. Participants will discuss the implications of these trends for public health policy and intervention strategies.

This session will explore effective public health strategies aimed at preventing HIV transmission and drug resistance. Emphasis will be placed on community engagement, education, and policy initiatives.

This track will examine the global landscape of HIV drug resistance, focusing on regional differences and challenges. Participants will share insights from various countries and discuss collaborative approaches to address these issues.

This session will look ahead to future research priorities in the field of HIV and drug resistance. Experts will discuss emerging trends, potential breakthroughs, and the role of interdisciplinary collaboration in advancing the field.